» Articles » PMID: 12908935

Molecular Epidemiology of Dual HIV-1/HIV-2 Seropositive Adults from Senegal, West Africa

Overview
Publisher Mary Ann Liebert
Date 2003 Aug 12
PMID 12908935
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Dual infection with HIV-1 and HIV-2 can occur in locales where these viruses co-circulate, most commonly in West Africa. Although dual seropositivity is common in this region, the true rate of dual infection remains unclear. In addition, whether unique HIV-1 subtypes are circulating in dually infected individuals is unknown. A cohort of 47 HIV-1 and HIV-2 dually seropositive individuals from Senegal, West Africa was screened for the presence of HIV-1 and HIV-2 gag and env PBMC viral DNA sequences using PCR. Of the 47 dual HIV-1/HIV-2 seropositive individuals tested, 19 (40.4%) had infection with both HIV-1 and HIV-2 confirmed by genetic sequence analysis, whereas only HIV-1 or HIV-2 was confirmed in 17 (36.2%) or 9 (19.1%), respectively. The majority of HIV-1 subtypes found were CRF-02 and A, although subtypes D, C, G, J and B were also found, reflecting the subtypes known to be circulating in Senegal. There was no significant difference in HIV-1 subtype distribution between individuals with confirmed dual infection and patients in this study with dual seropositivity but lacking HIV-2, or with HIV-1 infected patients within the general population in Senegal, although the study was underpowered to detect anything but large differences. The prevalence of HIV-1/HIV-2 dual infection appears to be significantly less than that of dually seropositive individuals and this likely reflects cross-reactive serology. The common HIV-1 subtypes prevalent in West Africa (CRF-02 and subtype A) have a similar distribution to those found in our cohort of dually infected and dually seropositive subjects.

Citing Articles

Future of HIV2 and HIV2 +  1 Infected Patients Treated with Antiretrovirals Followed at the Day Hospital HIV Care Unit from 2011 to 2015.

Diallo I, Ouedraogo S, Sawadogo A, Ouedraogo G, Diendere E, Zoungrana J J Int Assoc Provid AIDS Care. 2022; 21:23259582221143675.

PMID: 36474417 PMC: 9732798. DOI: 10.1177/23259582221143675.


Human Immunodeficiency Virus Type 2: The Neglected Threat.

Ceccarelli G, Giovanetti M, Sagnelli C, Ciccozzi A, DEttorre G, Angeletti S Pathogens. 2021; 10(11).

PMID: 34832533 PMC: 8621479. DOI: 10.3390/pathogens10111377.


Detection and differentiation of HIV-2 using the point-of-care Alere q HIV-1/2 Detect nucleic acid test.

Chang M, Steinmetzer K, Raugi D, Smith R, Ba S, Sall F J Clin Virol. 2017; 97:22-25.

PMID: 29096389 PMC: 5700839. DOI: 10.1016/j.jcv.2017.10.013.


A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa.

Whitham H, Hawes S, Chu H, Oakes J, Lifson A, Kiviat N Cancer Epidemiol Biomarkers Prev. 2017; 26(6):886-894.

PMID: 28515108 PMC: 5457347. DOI: 10.1158/1055-9965.EPI-16-0700.


Male Circumcision and the Epidemic Emergence of HIV-2 in West Africa.

Sousa J, Temudo M, Hewlett B, Camacho R, Muller V, Vandamme A PLoS One. 2016; 11(12):e0166805.

PMID: 27926927 PMC: 5142780. DOI: 10.1371/journal.pone.0166805.